The appearance of new variants produces changes in the most frequent symptoms in case of COVID-19. This is indicated by experts around the world who point to headaches and sore throats as the most recurring effects of suffering after an infection. However, others have emerged that are linked to the virus. It’s all about night sweats.
Night sweats are repeated episodes of extreme sweating at night. Are related to an underlying disease or medical condition. Additionally, and frequently, they have been associated with medical conditions ranging in severity from cancer to reproach but they hadn’t yet been associated with covid-19 until the omicron variant started spreading around the world. This symptom, in fact, is one of those that distinguishes this variant from other variants of the coronavirus.
Dr Amir Khan is a medical doctor in the National Health Service of UK and ensured that suspected cases consider night sweats as a specific symptom of the omicron variant of the coronavirus. Another renowned expert, virologist Luke O’Neill, also assured in an interview in Ireland that the BA.5 variant is more infectious than previous ones and is better able to evade previous infections and vaccine immunity. This is the predominant variant. “An additional symptom of BA.5 that I have seen is night sweats. The diseases it’s a bit different because the virus has changed. It could lead to a slightly different illness, with night sweats as a feature.”
Further investigations add another factor to the list of symptoms that would indicate the presence of omicron in the body: a hoarse or “creaky” voice, commonly known as a taken voice. A clear sign of the presence of this strain. This is because the pain or irritation in the throatas mentioned above, is one of the most common symptoms related to omicron.
Cuba has developed a new vaccine against the omicron variant of covid
This Monday, we knew that Cuba has developed an antigen against the omicron variant of the SARS-COV-2 coronavirus, which causes covid-19, which is ready for its next formulation as a vaccine candidate, state media reported on Monday.
The antigen, which was produced at the laboratory level by the island’s biopharmaceutical industry, is ready to begin the process of preclinical and clinical trials in humans, according to the president of the state group BioCubaFarma, Eduardo Martínez, quoted by the Granma newspaper. .
On the effectiveness of anti-covid vaccines, the scientist pointed out that the new variants of the coronavirus are increasingly evading induced immunity and even that obtained due to infection with the virus.
However, he felt that the three Cuban vaccines against covid still have a high level of protection against serious illness and death, especially when they have high antibody titers. The director mentioned that among the variants derived frommicron there is the BA.5, which caused a new epidemic of covid-19 in the world.